These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 23300840

  • 1. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
    Cao W, Ribeiro Rde O, Liu D, Saintigny P, Xia R, Xue Y, Lin R, Mao L, Ren H.
    PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
    Kikuchi J, Takashina T, Kinoshita I, Kikuchi E, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Marquez VE, Nishimura M, Dosaka-Akita H.
    Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
    [Abstract] [Full Text] [Related]

  • 3. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong R, Yang JS, Xu TP, Liu YW, Zou YF, Lu BB, Yin R, Zhang EB, Xu L, De W, Wang ZX.
    Cell Death Dis; 2014 Jun 26; 5(6):e1298. PubMed ID: 24967960
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.
    J Thorac Oncol; 2011 Apr 26; 6(4):671-8. PubMed ID: 21270667
    [Abstract] [Full Text] [Related]

  • 5. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer.
    Zhang H, Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, Wang S, Su J, Lv X, Liu H, Du W, Zhou W, Chen X, Fei K.
    Cell Physiol Biochem; 2013 Apr 26; 31(1):56-65. PubMed ID: 23343715
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W, Feng Z, Cui Z, Zhang C, Sun Z, Mao L, Chen W.
    Cancer; 2012 Jun 01; 118(11):2858-71. PubMed ID: 21989926
    [Abstract] [Full Text] [Related]

  • 7. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
    Liu JQ, Feng YH, Zeng S, Zhong MZ.
    Life Sci; 2020 Jan 15; 241():117134. PubMed ID: 31811854
    [Abstract] [Full Text] [Related]

  • 8. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C, Hao K, Hu H, Sheng Z, Yan J, Wang Q, Yu L.
    Lung Cancer; 2014 Nov 15; 86(2):268-73. PubMed ID: 25262426
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X, Liu Z, Liu Z, Feng X, Hua F, Hu X, Wang B, Lu K, Nie F.
    EBioMedicine; 2018 Nov 15; 37():177-187. PubMed ID: 30314898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.